Cargando…
Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model
BACKGROUND: Previous studies have reported that cancer stem cells (CSCs) play a key role in tumorigenesis, metastasis, and recurrence. CSC‐based vaccination confers better protection in tumor cells. However, isolation and cultivation of CSCs are difficult. This study aimed to explore the similaritie...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262930/ https://www.ncbi.nlm.nih.gov/pubmed/32314522 http://dx.doi.org/10.1111/1759-7714.13440 |
_version_ | 1783540717887422464 |
---|---|
author | Wang, Jingbo Shao, Lijuan Wu, Liujing Ma, Wei Zheng, Yuanyuan Hu, Chaofeng Li, Furong |
author_facet | Wang, Jingbo Shao, Lijuan Wu, Liujing Ma, Wei Zheng, Yuanyuan Hu, Chaofeng Li, Furong |
author_sort | Wang, Jingbo |
collection | PubMed |
description | BACKGROUND: Previous studies have reported that cancer stem cells (CSCs) play a key role in tumorigenesis, metastasis, and recurrence. CSC‐based vaccination confers better protection in tumor cells. However, isolation and cultivation of CSCs are difficult. This study aimed to explore the similarities between CSCs and induced pluripotent stem cells (iPSCs). METHODS: ALDH1+ cancer stem cells were isolated from lung adenocarcinoma patients and their gene expression patterns compared with human induced pluripotent stem cells (hiPSCs). In addition, a tumor vaccine was developed using hiPSC and unmethylated cytosine‐guanine (CpG). Finally, the antitumor properties of the vaccine were evaluated in a humanized mouse model. RESULTS: Preimmunization of iPSC+CpG elicited stronger antigen presentation and cytotoxic T cell response which suppressed the growth of tumors. Adoptive transfer of spleen T cells from the vaccine preimmunized mice inhibited tumor growth in unvaccinated recipients without any side effects. CONCLUSIONS: This study suggests a universal strategy for tumor therapy which simplifies future clinical procedures. Therefore, the application of hiPSC elicits tumor protective responses. |
format | Online Article Text |
id | pubmed-7262930 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-72629302020-06-03 Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model Wang, Jingbo Shao, Lijuan Wu, Liujing Ma, Wei Zheng, Yuanyuan Hu, Chaofeng Li, Furong Thorac Cancer Original Articles BACKGROUND: Previous studies have reported that cancer stem cells (CSCs) play a key role in tumorigenesis, metastasis, and recurrence. CSC‐based vaccination confers better protection in tumor cells. However, isolation and cultivation of CSCs are difficult. This study aimed to explore the similarities between CSCs and induced pluripotent stem cells (iPSCs). METHODS: ALDH1+ cancer stem cells were isolated from lung adenocarcinoma patients and their gene expression patterns compared with human induced pluripotent stem cells (hiPSCs). In addition, a tumor vaccine was developed using hiPSC and unmethylated cytosine‐guanine (CpG). Finally, the antitumor properties of the vaccine were evaluated in a humanized mouse model. RESULTS: Preimmunization of iPSC+CpG elicited stronger antigen presentation and cytotoxic T cell response which suppressed the growth of tumors. Adoptive transfer of spleen T cells from the vaccine preimmunized mice inhibited tumor growth in unvaccinated recipients without any side effects. CONCLUSIONS: This study suggests a universal strategy for tumor therapy which simplifies future clinical procedures. Therefore, the application of hiPSC elicits tumor protective responses. John Wiley & Sons Australia, Ltd 2020-04-20 2020-06 /pmc/articles/PMC7262930/ /pubmed/32314522 http://dx.doi.org/10.1111/1759-7714.13440 Text en © 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Wang, Jingbo Shao, Lijuan Wu, Liujing Ma, Wei Zheng, Yuanyuan Hu, Chaofeng Li, Furong Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model |
title | Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model |
title_full | Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model |
title_fullStr | Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model |
title_full_unstemmed | Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model |
title_short | Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model |
title_sort | expression levels of a gene signature in hipsc associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262930/ https://www.ncbi.nlm.nih.gov/pubmed/32314522 http://dx.doi.org/10.1111/1759-7714.13440 |
work_keys_str_mv | AT wangjingbo expressionlevelsofagenesignatureinhipscassociatedwithlungadenocarcinomastemcellsanditscapabilityinelicitingspecificantitumorimmuneresponseinahumanizedmicemodel AT shaolijuan expressionlevelsofagenesignatureinhipscassociatedwithlungadenocarcinomastemcellsanditscapabilityinelicitingspecificantitumorimmuneresponseinahumanizedmicemodel AT wuliujing expressionlevelsofagenesignatureinhipscassociatedwithlungadenocarcinomastemcellsanditscapabilityinelicitingspecificantitumorimmuneresponseinahumanizedmicemodel AT mawei expressionlevelsofagenesignatureinhipscassociatedwithlungadenocarcinomastemcellsanditscapabilityinelicitingspecificantitumorimmuneresponseinahumanizedmicemodel AT zhengyuanyuan expressionlevelsofagenesignatureinhipscassociatedwithlungadenocarcinomastemcellsanditscapabilityinelicitingspecificantitumorimmuneresponseinahumanizedmicemodel AT huchaofeng expressionlevelsofagenesignatureinhipscassociatedwithlungadenocarcinomastemcellsanditscapabilityinelicitingspecificantitumorimmuneresponseinahumanizedmicemodel AT lifurong expressionlevelsofagenesignatureinhipscassociatedwithlungadenocarcinomastemcellsanditscapabilityinelicitingspecificantitumorimmuneresponseinahumanizedmicemodel |